Publications by authors named "E Koutli"
Background: Access to the liver transplant waitlist for patients with hepatocellular carcinoma (HCC) depends on tumour presentation, biology, and response to treatments. The Milan Criteria (MC) represent the benchmark for expanded criteria that incorporate additional prognostic factors. The purpose of this study was to determine the added value of skeletal muscle index (SMI) in HCC patients beyond the MC.
View Article and Find Full Text PDFBackground And Aims: ElastPQ is a point shear wave elastography technique used to non-invasively assess liver fibrosis. We compared liver stiffness measurements (LSM) by ElastPQ and fibroscan transient elastography (F-TE) in a cohort of patients with non-alcoholic fatty liver disease (NAFLD). We further evaluated the performance of ElastPQ in a subgroup of patients with available liver histology.
View Article and Find Full Text PDFBackground: Identification of reliable outcome predictors in coronavirus disease 2019 (COVID-19) is of paramount importance for improving patient's management.
Methods: A systematic review of literature was conducted until 24 April 2020. From 6843 articles, 49 studies were selected for a pooled assessment; cumulative statistics for age and sex were retrieved in 587 790 and 602 234 cases.
Article Synopsis
- Juvenile idiopathic arthritis (JIA) is a group of inflammatory disorders that begins before age 16, with most children achieving remission, but some may have long-term symptoms in adulthood.
- There are concerns that JIA patients might have an increased risk of cardiovascular (CV) issues due to similarities with adult rheumatic diseases, and the review discusses evidence of CV involvement in JIA, risk factors, and arterial disease markers.
- The article emphasizes the need for a comprehensive management approach for JIA patients that includes monitoring CV risk factors, lifestyle changes, and the careful use of anti-inflammatory medications that are safe for heart health.
Background: Direct-acting antivirals (DAAs) offer high cure rates in people who inject drugs (PWID) with hepatitis C virus (HCV) infection. There are concerns regarding lower response rates among PWID in real life. We evaluated the outcome of DAA therapy in PWID in a real-world setting and the factors that affect it.
View Article and Find Full Text PDF